Beta-blockers may lessen frequency of injections

Intravenous nanoparticles used to treat wet AMD in mice Reading Beta-blockers may lessen frequency of injections 1 minute Next FDA approves myVisionTrack vision test to track eye health

By Dr. Paul KrawitzApr 15, 2013

Share

Patients being treated for wet macular degeneration with intravitreal injections of Avastin may require fewer injections if also treated with systemic beta-blockers. The recent study which involved 46 patients who had wet macular degeneration revealed that those patients who were also being treated with beta-blockers required on average 5.2 injections compared to 7.9 in those not on beta-blockers. Follow-up visits at 12 months noted an average gain of visual acuity of 0.9 letters and -2.1 letters at 24 months. A reduction in foveal thickness was also noted.*

Save $6.00